Business / Finance

RSS
Walgreens’ August sales increased by 5.6% to $6.17 billion

Walgreens’ August sales increased by 5.6% to $6.17 billion

Patheon's Q3 2013 revenues increase 30.4% to $265.7 million

Patheon's Q3 2013 revenues increase 30.4% to $265.7 million

ThromboGenics, Bicycle to develop and commercialize novel drugs for ophthalmic diseases

ThromboGenics, Bicycle to develop and commercialize novel drugs for ophthalmic diseases

Neurodyn acquires all assets related to new drug candidate Memogain from Galantos Pharma

Neurodyn acquires all assets related to new drug candidate Memogain from Galantos Pharma

Affinium initiates dosing in Phase 1 IV clinical trial of antibiotic prodrug, AFN-1720

Affinium initiates dosing in Phase 1 IV clinical trial of antibiotic prodrug, AFN-1720

Sanofi, POZEN ink license agreement to commercialize PA8140 and PA32540 tablets in US

Sanofi, POZEN ink license agreement to commercialize PA8140 and PA32540 tablets in US

Rochester Medical enters into definitive merger agreement with C. R. Bard

Rochester Medical enters into definitive merger agreement with C. R. Bard

Viralytics releases financial results for 2013

Viralytics releases financial results for 2013

Sanomedics completes acquisition of Prime Time Medical

Sanomedics completes acquisition of Prime Time Medical

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.